These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34991432)

  • 1. Relationship between Primary Tumor Resection for Metastatic Small Intestine Neuroendocrine Tumors and Survival: A Propensity Score-Matched Analysis.
    Yan H; Yin L; Han H; Jin Y; Liu Z
    J Invest Surg; 2022 Jun; 35(6):1239-1247. PubMed ID: 34991432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
    Tsilimigras DI; Hyer JM; Paredes AZ; Ejaz A; Cloyd JM; Beane JD; Dillhoff M; Tsung A; Pawlik TM
    J Gastrointest Surg; 2021 Sep; 25(9):2368-2376. PubMed ID: 33403563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
    Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
    J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
    Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
    J Neuroendocrinol; 2024 Aug; 36(8):e13399. PubMed ID: 38760997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of the primary tumor improves the prognosis of gastrointestinal neuroendocrine neoplasms with liver metastases: mutual validation based on SEER database and institutional data.
    Liu Y; Wang Z; Lin Q; Cui R; Tang W; Li G; Wang Z
    BMC Gastroenterol; 2023 Nov; 23(1):408. PubMed ID: 37993767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of optimal primary tumor resection candidates for metastatic gastric cancer: Nomograms based on propensity score matching.
    Li Z; Zheng H; Zhao Z; Chen G; Wang Z; Amin B; Zhang N
    Cancer Med; 2023 Jun; 12(12):13063-13075. PubMed ID: 37096953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of primary tumor resection for gastric cancer with liver metastasis: A propensity score-matched, population-based study.
    Wu J; Yu J; Chen Z; Zhu H; Zhong C; Liang Y; Mai Z; Lin Z; Wan Y; Li G
    Front Oncol; 2022; 12():1039086. PubMed ID: 36465378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.
    Mao K; Yan Y; Zhang J; Wang J; Wang R; Ling X; Liu Y; Lau WY; Jiang S; Liu J; Xiao Z
    Cancer Med; 2018 Sep; 7(9):4475-4484. PubMed ID: 30117307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Ye H; Xu HL; Shen Q; Zheng Q; Chen P
    J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable survival benefit of local excision versus radical resection for 10- to 20-mm rectal neuroendocrine tumors.
    Chen Q; Chen J; Huang Z; Zhao H; Cai J
    Eur J Surg Oncol; 2022 Apr; 48(4):864-872. PubMed ID: 34753616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based propensity-matched study of regional dissections in patients with metastatic osteosarcoma.
    Wang W; Ding H; Sun Z; Jin C; Zhu Y; Wang X
    J Orthop Surg Res; 2020 Mar; 15(1):107. PubMed ID: 32169092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
    Lewis A; Raoof M; Ituarte PHG; Williams J; Melstrom L; Li D; Lee B; Singh G
    Ann Surg; 2019 Dec; 270(6):1131-1137. PubMed ID: 29746336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.
    Zhou Z; Ge H; Li Y; Wang D; Güngör C
    PLoS One; 2022; 17(6):e0270608. PubMed ID: 35749551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.
    Zhu H; Zhao S; Zhang C; Ji K; Wu W; Yin L; Yan H; Zhou J; Tang R; Miao L
    Surg Endosc; 2022 Apr; 36(4):2488-2498. PubMed ID: 33987767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumor resection in metastatic breast cancer: A propensity-matched analysis, 1988-2011 SEER data base.
    Vohra NA; Brinkley J; Kachare S; Muzaffar M
    Breast J; 2018 Jul; 24(4):549-554. PubMed ID: 29498453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
    Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
    Front Oncol; 2022; 12():930491. PubMed ID: 35912176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
    Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
    BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching.
    Tao Z; Deng X; Ding Z; Guo B; Fan Y
    Sci Rep; 2024 Jul; 14(1):17260. PubMed ID: 39068197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.
    Polcz M; Schlegel C; Edwards GC; Wang F; Tan M; Kiernan C; Solórzano CC; Idrees K; Parikh A; Bailey CE
    Ann Surg Oncol; 2020 Aug; 27(8):2795-2803. PubMed ID: 32430752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.